Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2340-2350

  Ebisch, Inge M W ^a   Thomas, Chris M G ^a   Wetzels, Alex M M ^a   Willemsen, Wim N P ^a   Sweep, Fred C G J ^a   Steegers Theunissen, Régine P M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fertilisation; plasminogen activator inhibitor type 1; tissue type plasminogen activator; urokinase type plasminogen activator; vascular endothelial growth factor

Indexed keywords

PLASMINOGEN ACTIVATOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD TESTIS BARRIER; CORPUS LUTEUM; FEMALE GENITAL SYSTEM; FERTILIZATION; HUMAN; MALE GENITAL SYSTEM; OVARY FOLLICLE FLUID; OVULATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SPERMATOZOON; SPERMATOZOON MOTILITY; SUBFERTILITY; ZONA PELLUCIDA;

EID: 56649083394     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.026     Document Type: Article

References (103)

1. Philippov O.S., Radionchenko A.A., Bolotova V.P., Voronovskaya N.I., and Potemkina T.V. Estimation of the prevalence and causes of infertility in western Siberia. Bull World Health Organ 76 (1998) 183-187
2. Snick H.K., Snick T.S., Evers J.L., and Collins J.A. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod 12 (1997) 1582-1588
3. Whiteford L.M., and Gonzalez L. Stigma: the hidden burden of infertility. Soc Sci Med 40 (1995) 27-36
4. Mandriota S.J., Seghezzi G., Vassalli J.D., Ferrara N., Wasi S., Mazzieri R., et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270 (1995) 9709-9716
5. Pepper M.S., Ferrara N., Orci L., and Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181 (1991) 902-906
6. Saksela O., and Rifkin D.B. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4 (1988) 93-126
7. Dano K., Andreasen P.A., Grondahl-Hansen J., Kristensen P., Nielsen L.S., and Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44 (1985) 139-266
8. Degen S.J., Rajput B., and Reich E. The human tissue plasminogen activator gene. J Biol Chem 261 (1986) 6972-6985
9. Eaton D.L., Scott R.W., and Baker J.B. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem 259 (1994) 6241-6247
10. Wun T.C., Ossowski L., and Reich E. A proenzyme form of human urokinase. J Biol Chem 257 (1982) 7262-7268
11. Andreasen P.A., Nielsen L.S., Grondahl-Hansen J., Skriver L., Zeuthen J., Stephens R.W., et al. Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. EMBO J 3 (1984) 51-56
12. Rijken D.C., Hoylaerts M., and Collen D. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 257 (1982) 2920-2925
13. Schmitt M., Harbeck N., Thomssen C., Wilhelm O., Magdolen V., Reuning U., et al. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78 (1997) 285-296
14. Vassalli J.D., Baccino D., and Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100 (1985) 86-92
15. Griswold M.D. Interactions between germ cells and Sertoli cells in the testis. Biol Reprod 52 (1995) 211-216
16. Zhang T., Zhou H.M., and Liu Y.X. Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes. Mol Hum Reprod 3 (1997) 223-231
17. Lacroix M., Smith F.E., and Fritz I.B. Secretion of plasminogen activator by Sertoli cell enriched cultures. Mol Cell Endocrinol 9 (1977) 227-236
18. Liu Y.X., Liu K., Zhou H.M., Du Q., Hu Z.Y., and Zou R.J. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured monkey Sertoli cells. Hum Reprod 10 (1995) 719-727
19. Tolli R., Monaco L., Di Bonito P., and Canipari R. Hormonal regulation of urokinase- and tissue- type plasminogen activator in rat Sertoli cells. Biol Reprod 53 (1995) 193-200
20. Liu Y., Du Q., Zhou H., Liu K., and Hu Z. Regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured rat Sertoli and Leydig cells. Sci China C Life Sci 39 (1996) 37-44
21. Vihko K.K., Suominen J.J., and Parvinen M. Cellular regulation of plasminogen activator secretion during spermatogenesis. Biol Reprod 31 (1984) 383-389
22. Vihko K.K., Toppari J., Saksela O., Suominen J.J., and Parvinen M. Testicular plasminogen activators during postnatal development in the rat. Acta Endocrinol (Copenh) 112 (1986) 431-435
23. Zhou H.M., and Liu Y.X. Localization of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor type-1 (PAI-1) messenger RNA (mRNA) in rat testis. Chin Sci Bull 41 (1996) 455-458
24. Magueresse-Battistoni B., Pernod G., Sigillo F., Kolodie L., and Benahmed M. Plasminogen activator inhibitor-1 is expressed in cultured rat Sertoli cells. Biol Reprod 59 (1998) 591-598
25. Liu Y.X., Du Q., Hu Z.Y., and Tor N. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 gene expression in cultured mouse Sertoli cells. Sci China B 36 (1993) 319-328
26. Zhang T., Guo C.X., Hu Z.Y., and Liu Y.X. Localization of plasminogen activator and inhibitor, LH and androgen receptors and inhibin subunits in monkey epididymis. Mol Hum Reprod 3 (1997) 945-952
27. Hettle J.A., Waller E.K., and Fritz I.B. Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cells. Biol Reprod 34 (1986) 895-904
28. Vihko K.K., Penttila T.L., Parvinen M., and Belin D. Regulation of urokinase- and tissue-type plasminogen activator gene expression in the rat seminiferous epithelium. Mol Endocrinol 3 (1989) 52-59
29. Nargolwalla C., McCabe D., and Fritz I.B. Modulation of levels of messenger RNA for tissue-type plasminogen activator in rat Sertoli cells, and levels of messenger RNA for plasminogen activator inhibitor in testis peritubular cells. Mol Cell Endocrinol 70 (1990) 73-80
30. Le Blond C.P., and Clermont Y. Definition of the stages of the cycle of the seminiferous epithelium in the rat. Ann NY Acad Sci 55 (1952) 548-573
31. Morales C., Clermont Y., and Nadler N.J. Cyclic endocytic activity and kinetics of lysosomes in Sertoli cells of the rat: a morphometric analysis. Biol Reprod 34 (1986) 207-218
32. Penttila T.L., Kaipia A., Toppari J., Parvinen M., and Mali P. Localization of urokinase- and tissue-type plasminogen activator mRNAs in rat testes. Mol Cell Endocrinol 105 (1994) 55-64
33. Ailenberg M., and Fritz I.B. Influences of follicle-stimulating hormone, proteases, and antiproteases on permeability of the barrier generated by Sertoli cells in a two-chambered assembly. Endocrinology 124 (1989) 1399-1407
34. Huarte J., Belin D., Bosco D., Sappino A.P., and Vassalli J.D. Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface. J Cell Biol 104 (1987) 1281-1289
35. Larsson L.I., Skriver L., Nielsen L.S., Grondahl-Hansen J., Kristensen P., and Dano K. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 98 (1984) 894-903
36. Eddy E.M., Vernon R.B., Muller C.H., Hahnel A.C., and Fenderson B.A. Immunodissection of sperm surface modifications during epididymal maturation. Am J Anat 174 (1985) 225-237
37. Tulsiani D.R., NagDas S.K., Skudlarek M.D., and Orgebin-Crist M.C. Rat sperm plasma membrane mannosidase: localization and evidence for proteolytic processing during epididymal maturation. Dev Biol 167 (1995) 584-595
38. Talbot P., and Chacon R. Detection of modifications in the tail of capacitated guinea pig sperm using lectins. J Exp Zool 216 (1981) 435-444
39. Pillai M.C., and Meizel S. Trypsin inhibitors prevent the progesterone-initiated increase in intracellular calcium required for the human sperm acrosome reaction. J Exp Zool 258 (1991) 384-393
40. Saling P.M. Involvement of trypsin-like activity in binding of mouse spermatozoa to zonae pellucidae. Proc Natl Acad Sci USA 78 (1981) 6231-6235
41. Smokovitis A., Kokolis N., Alexopoulos C., Alexali E., and Eleftheriou E. Plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition in spermatozoa and seminal plasma of man and various animal species-effect of plasmin on sperm motility. Fibrinolysis 1 (1987) 253-257
42. Reese J.H., McNeal J.E., Redwine E.A., Stamey T.A., and Freiha F.S. Tissue type plasminogen activator as a marker for functional zones, within the human prostate gland. Prostate 12 (1988) 47-53
43. Smokovitis A., Kokolis N., Taitzoglou I., and Rekkas C. Plasminogen activator: the identification of an additional proteinase at the outer acrosomal membrane of human and boar spermatozoa. Int J Fertil 37 (1992) 308-314
44. Liu K., Liu Y.X., Qun D., Zhou H.M., Lin X., Hu Z.Y., et al. Preliminary studies on the role of plasminogen activator in seminal plasma of human and rhesus monkey. Mol Hum Reprod 2 (1996) 99-104
45. Liu Y.X., Cajander S.B., Ny T., Kristensen P., and Hsueh A.J. Gonadotropin regulation of tissue-type and urokinase-type plasminogen activators in rat granulosa and theca-interstitial cells during the periovulatory period. Mol Cell Endocrinol 54 (1987) 221-229
46. Ny T., Bjersing L., Hsueh A.J., and Loskutoff D.J. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins. Endocrinology 116 (1985) 1666-1668
47. Canipari R., O'Connell M.L., Meyer G., and Strickland S. Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator. J Cell Biol 105 (1987) 977-981
48. O'Connell M.L., Canipari R., and Strickland S. Hormonal regulation of tissue plasminogen activator secretion and mRNA levels in rat granulosa cells. J Biol Chem 262 (1987) 2339-2344
49. Macchione E., Epifano O., Stefanini M., Belin D., and Canipari R. Urokinase redistribution from the secreted to the cell-bound fraction in granulosa cells of rat preovulatory follicles. Biol Reprod 62 (2000) 895-903
50. Canipari R., and Strickland S. Plasminogen activator in the rat ovary. Production and gonadotropin regulation of the enzyme in granulosa and thecal cells. J Biol Chem 260 (1985) 5121-5125
51. Tsafriri A., Bicsak T.A., Cajander S.B., Ny T., and Hsueh A.J. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. Endocrinology 124 (1989) 415-421
52. Liu Y.X., Ny T., Sarkar D., Loskutoff D., and Hsueh A.J. Identification and regulation of tissue plasminogen activator activity in rat cumulus-oocyte complexes. Endocrinology 119 (1986) 1578-1587
53. Liu Y.X., and Hsueh A.J. Plasminogen activator activity in cumulus-oocyte complexes of gonadotropin-treated rats during the periovulatory period. Biol Reprod 36 (1987) 1055-1062
54. D'Alessandris C., Canipari R., Di Giacomo M., Epifano O., Camaioni A., Siracusa G., et al. Control of mouse cumulus cell-oocyte complex integrity before and after ovulation: plasminogen activator synthesis and matrix degradation. Endocrinology 142 (2001) 3033-3040
55. Colgin D.C., and Murdoch W.J. Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator. Anim Reprod Sci 47 (1997) 197-204
56. Bacharach E., Itin A., and Keshet E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 89 (1992) 10686-10690
57. Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368 (1994) 419-424
58. Leonardsson G., Peng X.R., Liu K., Nordstrom L., Carmeliet P., Mulligan R., et al. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators. Proc Natl Acad Sci USA 92 (1995) 12446-12450
59. Ny T., Peng X.R., and Ohlsson M. Hormonal regulation of the fibrinolytic components in the ovary. Thromb Res 71 (1993) 1-45
60. Hägglund A.C., Ny A., Liu K., and Ny T. Coordinated and cell-specific induction of both pyshiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Endocrinology 137 (1996) 5671-5677
61. Li M., Karakji E.G., Xing R., Fryer J.N., Carnegie J.A., Rabbani S.A., et al. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development. Endocrinology 138 (1997) 2790-2799
62. Liu K., Liu Y.X., Hu Z.Y., Zou R.Y., Chen Y.J., Mu X.M., et al. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression. Mol Cell Endocrinol 133 (1997) 109-116
63. Jones PBC, Vernon MW, Muse KN, Curry TE Jr. Plasminogen activator and plasminogen activator inhibitor in human preovulatory follicular fluid. J Clin Endocrinol Metab 189;68:1039-45.
64. Spyridopoulos I., Brogi E., Kearney M., Sullivan A.B., Cetrulo C., Isner J.M., et al. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-α: balance between growth and death signals. J Mol Cell Cardiol 29 (1997) 1321-1330
65. Le Gouill S., Podar K., Amiot M., Hideshima T., Chauhan D., Ishitsuka K., et al. VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis. Blood 104 (2004) 2886-2892
66. Yamanaka M., Shirai M., Shiina H., Tanaka Y., Enokida H., Tsujimura A., et al. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 173 (2005) 318-323
67. Foster R.R., Saleem M.A., Mathieson P.W., Bates D.O., and Harper S.J. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 288 (2005) 48-57
68. Berkkanoglu M., Guzeloglu-Kayisli O., Kayisli U.A., Selam B.F., and Arici A. Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro. Mol Hum Reprod 10 (2004) 393-398
69. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 (2002) 954-958
70. Gerber H.P., Dixit V., and Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273 (1998) 13313-13316
71. Nor J.E., Christensen J., Mooney D.J., and Polverini P.J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154 (1999) 375-384
72. Roybal C.N., Yang S., Sun C.W., Hurtado D., Van der Jagt D.L., Townes T.M., et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 279 (2004) 14844-14852
73. Bassus S., Herkert O., Kronemann N., Gorlach A., Bremerich D., Kirchmaier C.M., et al. Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species. Arterioscler Thromb Vasc Biol 21 (2001) 1550-1555
74. Kuroki M., Voest E.E., Amano S., Beerepoot L.V., Takashima S., Tolentino M., et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98 (1996) 1667-1675
75. Chua C.C., Hamdy R.C., and Chua B.H. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 25 (1998) 891-897
76. Redondo P., Jimenez E., Perez A., and Garcia-Foncillas J. N-acetylcysteine downregulates vascular endothelial growth factor production by human keratinocytes in vitro. Arch Dermatol Res 292 (2000) 621-628
77. Pepper M.S., and Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32 (1990) 319-327
78. Brown L.F., Yeo K.T., Berse B., Morgentaler A., Dvorak H.F., and Rosen S. Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J Urol 154 (1995) 576-579
79. Yeo K.T., Wang H.H., Nagy J.A., Sioussat T.M., Ledbetter S.R., Hoogewerf A.J., et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53 (1993) 2912-2918
80. Ergun S., Kilic N., Fiedler W., and Mukhopadhyay A.K. Vascular endothelial growth factor and its receptors in normal human testicular tissue. Mol Cell Endocrinol 131 (1997) 9-20
81. Obermair A., Obruca A., Pohl M., Kaider A., Vales A., Leodolter S., et al. Vascular endothelial growth factor and its receptors in male fertility. Fertil Steril 72 (1999) 269-275
82. Huminiecki L., Chan H.Y., Lui S., Poulsom R., Stamp G., Harris A.L., et al. Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection. Mol Hum Reprod 7 (2001) 255-264
83. Korpelainen E.I., Karkkainen M.J., Tenhunen A., Lakso M., Rauvala H., Vierula M., et al. Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. J Cell Biol 143 (1998) 1705-1712
84. Geva E., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 429-438
85. Christenson L.K., and Stouffer R.L. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 82 (1997) 2135-2142
86. Laitinen M., Ristimaki A., Honkasalo M., Narko K., Paavonen K., and Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 138 (1997) 4748-4756
87. Fujimoto J., Sakaguchi H., Hirose R., Ichigo S., and Tamaya T. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer 83 (1998) 2528-2533
88. Otani N., Minami S., Yamoto M., Shikone T., Otani H., Nishiyama R., et al. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 84 (1999) 3845-3851
89. Ravindranath N., Little-Ihrig L., Phillips H.S., Ferrara N., and Zeleznik A.J. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131 (1992) 254-260
90. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., and Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91 (1993) 2235-2243
91. Olofsson B., Korpelainen E., Pepper M.S., Mandriota S.J., Aase K., Kumar V., et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95 (1998) 11709-11714
92. Ferrara N., Chen H., Davis-Smyth T., Gerber H.P., Nguyen T.N., Peers D., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4 (1998) 336-340
93. Friedman C.I., Seifer D.B., Kennard E.A., Arbogast L., Alak B., and Danforth D.R. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril 70 (1998) 836-839
94. Asimakopoulos B., Nikolettos N., Papachristou D.N., Simopoulou M., Al Hasani S., and Diedrich D. Follicular fluid levels of vascular endothelial growth factor and leptin are associated with pregnancy outcome of normal women participating in intracytoplasmic sperm injection cycles. Physiol Res 54 (2005) 263-270
95. Lee A., Christenson L.K., Stouffer R.L., Burry K.A., and Patton P.E. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 68 (1997) 305-311
96. Ocal P., Aydin S., Cepni I., Idil S., Idil M., Uzun H., et al. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?. Eur J Obstet Gynecol Reprod Biol 115 (2004) 194-199
97. Tozer A.J., Iles R.K., Iammarrone E., Gillott C.M., Al Shawaf T., and Grudzinskas J.G. The effects of "coasting" on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome. Hum Reprod 19 (2004) 522-528
98. Kim K.H., Oh D.S., Jeong J.H., Shin B.S., Joo B.S., and Lee K.S. Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations. Fertil Steril 82 (2004) 586-592
99. Attar E., Genc S., Bulgurcuoglu S., Topuz S., and Serdaroglu H. Increased concentration of vascular endothelial growth factor in the follicular fluid of patients with endometriosis does not affect the outcome of in vitro fertilization-embryo transfer. Fertil Steril 80 (2003) 1518-1520
100. Ludwig M., Jelkmann W., Bauer O., and Diedrich K. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 14 (1999) 2437-2441
101. Meldrum D.R. Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil Steril 78 (2002) 1170-1171
102. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 6 (2000) 45-55
103. Tan X.J., Lang J.H., Liu D.Y., Shen K., Leng J.H., and Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78 (2002) 148-153